Unicycive Therapeutics Inc
UNCY
$4.11+0.98%
End of day · as of Oct 11, 2026, 8:01 AM ET
Mkt cap
$195.04M
EV/Sales
N/A
P/E ratio
N/A
Revenue (qtr ended 2023-09-30)
$675,000
EPS (H1 2026)
$-0.57
Gross Margin (qtr ended 2023-09-30)
N/A
Profit Margin (qtr ended 2023-09-30)
-641.93%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Unicycive Therapeutics Inc (UNCY) is a biotechnology company listed on NASDAQ.
Latest reported UNCY revenue for 2023-09-30 was $675.0K. Net income was -$4.3M. Revenue was up 0.0% from 2023-06-30 to 2023-09-30. UNCY currently screens at market cap $195.0M.
Use this UNCY research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full UNCY income, balance, and cash tables.
Unicycive Therapeutics Inc (UNCY) is a biotechnology company in the Healthcare sector.
Latest cached Unicycive Therapeutics Inc (UNCY) revenue for Sep 30, 2023 was $675.0K. Net income was -$4.3M. Statements: https://lician.com/financials/uncy
Unicycive Therapeutics Inc (UNCY) market capitalization is $195.0M on the latest cached snapshot.
Unicycive Therapeutics Inc (UNCY) cached previous close $4.07; day range $4.05 – $4.20; volume 549,361. Session quote: https://lician.com/quote/uncy
Unicycive Therapeutics Inc (UNCY) latest cached earnings event is "UNCY earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached UNCY filing is 8-K · Sep 29, 2026. Filings: https://lician.com/sec/uncy